Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.56 |
| ▸ | CTSK | P43235 | 1/20 | 0.56 |
| ▸ | REN | P00797 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 11/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.41 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30064531 | 0.94 | CTSS (0.63) | CTSSCTSKRENCA2BACE1 | |
| SCHEMBL29918303 | 0.92 | CTSS (0.55) | CTSSCTSKRENCA2BACE1 | |
| SCHEMBL30064525 | 0.91 | CTSS (0.56) | CTSSCTSKRENCA2BACE1 | |
| SCHEMBL10144023 | 0.85 | CTSS (0.59) | CTSSCTSKRENCA2BACE1 | |
| SCHEMBL29918031 | 0.82 | KMT2A (0.47) | CTSSCTSKCA2KDM4EMAPT | |
| SCHEMBL29918107 | 0.82 | KMT2A (0.47) | CTSSCTSKCA2KDM4EMAPT | |
| SCHEMBL27704332 | 0.80 | CTSK (0.64) | CTSSCTSKCA2TSHRKDM4E | |
| SCHEMBL27688713 | 0.80 | CTSK (0.64) | CTSSCTSKCA2TSHRKDM4E | |
| SCHEMBL27483577 | 0.80 | CTSK (0.64) | CTSSCTSKCA2TSHRKDM4E | |
| SCHEMBL29865883 | 0.79 | CTSS (0.58) | CTSSCTSKRENCA2BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-3786151-B1 | METHOD FOR PRODUCING AMIDE COMPOUND | CHUBU UNIV EDUCATIONAL FOUNDATION (JP) | 2023-06-07 | — | — | EP | disclosed |
| CN-112020492-B | Method for producing amide compound | 学校法人中部大学 | 2023-05-05 | — | — | CN | disclosed |
| US-11512108-B2 | Method for producing amide compound | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2022-11-29 | — | — | US | disclosed |
| EP-4053101-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | Chubu University Educational Foundation (JP) | 2022-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | NAAA, FAAH, FAAH2 | CTSS 392/4885CTSK 593/4885REN 1111/4885 |
| US-11512108-B2 | Method for producing amide compound | BCAT2, ASNS, VIP | CTSS 873/4885CTSK 812/4885REN 172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.